Literature DB >> 28859905

Atrazine suppresses FSH-induced steroidogenesis and LH-dependent expression of ovulatory genes through PDE-cAMP signaling pathway in human cumulus granulosa cells.

Kristina Pogrmic-Majkic1, Dragana Samardzija2, Natasa Stojkov-Mimic2, Jelena Vukosavljevic3, Aleksandra Trninic-Pjevic3, Vesna Kopitovic3, Nebojsa Andric2.   

Abstract

Atrazine (ATR) alters female reproductive functions in different animal species. Here, we analyzed whether ATR disturbs steroidogenic and ovulatory processes in hormone-stimulated human cumulus granulosa cells and mechanism of its action. Results showed that treatment of human cumulus granulosa cells with 20 μM ATR for 48 h resulted in lower FSH-stimulated estradiol and progesterone production. ATR reduced mRNA levels of aromatase (CYP19A1), steroidogenic acute regulatory protein (STAR) and luteinizing hormone/choriogonadotropin receptor (LHCGR). Addition of hCG 48 h after FSH and ATR treatment did not trigger maximal expression of the ovulatory genes amphiregulin (AREG) and epiregulin (EREG). Mechanistic experiments showed that ATR activated cPDE and decreased cAMP level. Addition of total PDE and specific PDE4 inhibitors, IBMX and rolipram, prevented ATR's action on CYP19A1 and STAR mRNA expression in FSH-stimulated human cumulus granulosa cells. This study suggests that ATR alters steroidogenesis and ovulatory process in human cumulus granulosa cells jeopardizing female reproduction.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrazine; Human cumulus granulosa cells; Ovulatory processes; Steroidogenesis; cAMP/PDE

Mesh:

Substances:

Year:  2017        PMID: 28859905     DOI: 10.1016/j.mce.2017.08.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Effects of Environment and Lifestyle Factors on Anovulatory Disorder.

Authors:  Ying Song; Rong Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Regulation of Insulin-Like Growth Factor 2 by Oocyte-Secreted Factors in Primary Human Granulosa Cells.

Authors:  Elie Hobeika; Marah Armouti; Michele A Fierro; Nichola Winston; Humberto Scoccia; Alberuni M Zamah; Carlos Stocco
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

Review 4.  Mechanisms of action of agrochemicals acting as endocrine disrupting chemicals.

Authors:  Genoa R Warner; Vasiliki E Mourikes; Alison M Neff; Emily Brehm; Jodi A Flaws
Journal:  Mol Cell Endocrinol       Date:  2019-12-12       Impact factor: 4.102

5.  Oocyte-secreted factors strongly stimulate sFRP4 expression in human cumulus cells.

Authors:  Sahar Esfandyari; Nicola J Winston; Michelle A Fierro; Humberto Scoccia; Carlos Stocco
Journal:  Mol Hum Reprod       Date:  2021-05-29       Impact factor: 4.025

6.  The effects of atrazine on the microbiome of the eastern oyster: Crassostrea virginica.

Authors:  Adrian Britt; Megan Bernini; Benjamin McSweeney; Sony Dalapati; Sophia Duchin; Kathryn Cavanna; Nicolette Santos; Grace Donovan; Katherine O'Byrne; Sarah Noyes; Manuela Romero; Kavery Nivana Theethira Poonacha; Tara Scully
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

7.  Mitochondrial sub-cellular localization of cAMP-specific phosphodiesterase 8A in ovarian follicular cells.

Authors:  Amel Lounas; Nathalie Vernoux; Marc Germain; Marie-Eve Tremblay; François J Richard
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

Review 8.  Pesticides: formulants, distribution pathways and effects on human health - a review.

Authors:  Valeriya P Kalyabina; Elena N Esimbekova; Kseniya V Kopylova; Valentina A Kratasyuk
Journal:  Toxicol Rep       Date:  2021-06-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.